Fiduciary Alliance LLC Invests $4.07 Million in Colgate-Palmolive (NYSE:CL)

Fiduciary Alliance LLC purchased a new position in shares of Colgate-Palmolive (NYSE:CL - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 44,729 shares of the company's stock, valued at approximately $4,066,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Czech National Bank boosted its position in Colgate-Palmolive by 6.4% during the 4th quarter. Czech National Bank now owns 177,145 shares of the company's stock worth $16,104,000 after purchasing an additional 10,696 shares during the period. Graypoint LLC raised its holdings in shares of Colgate-Palmolive by 16.4% during the 4th quarter. Graypoint LLC now owns 6,995 shares of the company's stock valued at $636,000 after buying an additional 988 shares during the period. Bruce G. Allen Investments LLC lifted its position in Colgate-Palmolive by 5.6% during the 4th quarter. Bruce G. Allen Investments LLC now owns 5,596 shares of the company's stock worth $509,000 after acquiring an additional 295 shares in the last quarter. Harbor Capital Advisors Inc. boosted its holdings in Colgate-Palmolive by 5.3% in the 4th quarter. Harbor Capital Advisors Inc. now owns 13,874 shares of the company's stock worth $1,261,000 after acquiring an additional 702 shares during the period. Finally, Hilltop National Bank grew its position in Colgate-Palmolive by 22.3% in the fourth quarter. Hilltop National Bank now owns 2,409 shares of the company's stock valued at $219,000 after acquiring an additional 440 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Stock Performance

Shares of NYSE:CL traded up $0.66 during trading hours on Monday, hitting $87.02. The stock had a trading volume of 8,182,930 shares, compared to its average volume of 5,300,290. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The stock's fifty day simple moving average is $92.49 and its 200 day simple moving average is $97.98. The firm has a market capitalization of $71.10 billion, a price-to-earnings ratio of 24.93, a PEG ratio of 3.31 and a beta of 0.44. Colgate-Palmolive has a 1-year low of $79.69 and a 1-year high of $109.30.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.30%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on CL shares. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and dropped their price target for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. StockNews.com lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Thursday. TD Cowen cut their target price on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a research report on Wednesday, January 8th. Wells Fargo & Company decreased their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a research report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an "overweight" rating in a research note on Friday, October 11th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $103.63.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business's stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.34% of the company's stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.